{"cik":1842295,"taxonomy":"us-gaap","tag":"DeferredTaxAssetsNet","label":"Deferred Tax Assets, Net of Valuation Allowance","description":"Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.","entityName":"MAZE THERAPEUTICS, INC.","units":{"USD":[{"end":"2024-12-31","val":93446000,"accn":"0001193125-26-122778","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-25","frame":"CY2024Q4I"},{"end":"2025-12-31","val":116286000,"accn":"0001193125-26-122778","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-25","frame":"CY2025Q4I"}]}}